ctDNA dynamics and neoadjuvant treatment responses in patients with resectable NSCLC from the phase 3 AEGEAN trial

Category Primary study
ConferenceOncology Research and Treatment
Year 2024
This article has no abstract
Epistemonikos ID: c817706cc7dc7a87db6a9bf20b0732b18e9a38aa
First added on: Apr 30, 2026